Abbvie business starts sales of Lastacaft (alcaftadine solution/0.25%) eye drops, licensed from innovator Vistakon Pharmaceuticals, approved through an sNDA. Full switch removes Lastacaft from Rx sales in US.
The number of drug ingredients for indicated for eye allergy relief available OTC in the US grows by one as Allergan plc doubles its brand footprint in nonprescription eye drops with the launch of Lastacaft.
The AbbVie Inc. business on 15 March announced the start of sales of Lastacaft (alcaftadine solution/0.25%) eye drops approved...
Germany’s Expert Committee for Prescription supports the Rx-to-OTC switches of melatonin and buccal acyclovir but rejects rupatadine.
Navamedic adds Ventizolve to its portfolio shortly after Norway switched the opioid overdose reversal drug from Rx to OTC.
Now available without a prescription, Dymista Control is the first OTC combination treatment for consumers who are struggling to control their seasonal allergic rhinitis with a corticosteroid or antihistamine nasal spray, according to the firm.
Creating a working group to drive Rx-to-OTC switch is one of the ways in which Finland could expand self-care and save €60m per year for the country's health system, suggests a recently published report commissioned by Haleon.
Representing about a fifth of all licensed medicines in the UK, OTCs are considered a critical part of the country's health system, according to a recently published Department of Health and Social Care (DHSC) paper on UK medicines supply issues.
Limits so effective that states are relaxing restrictions they previously set exceeding the nationwide limit Congress imposed in Combat Meth Act in 2006 on the amount of PSE, as well as a second meth precursor, ephedrine, in OTC drugs consumers can purchase daily.
A recently publshed, Bayer-supported, randomized, double-blind study found that functional dyspepsia sufferers using Iberogast reported feeling less full and bloated compared to those on a placebo.
